Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Retinoblastoma × Topotecan × Clear all

Phase

Phase 3 2 Phase 2 2 Phase 1 2 Phase NA 1 Phase EARLY_PHASE1 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Ovarian Neoplasms 3 Fallopian Tube Neoplasms 3 Small Cell Lung Carcinoma 1 Retinoblastoma 1 Carcinoma, Ovarian Epithelial 1

Interventions

Vincristine 1 Topotecan 1 Platinum Compounds 1 Melphalan 1 Hyperthermia, Induced 1 Etoposide 1 Drug Therapy 1 Cryotherapy 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04681417 2025-11-28

RETINO 2018

Institut Curie

Phase 2/3 Recruiting

Other solid neoplasm

Retinoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡